Caffeine intake and small-for-gestational-age birth: Modifying effects of xenobiotic-metabolising genes and smoking

Paediatric and Perinatal Epidemiology

Volumn 21, Issue 4, 2007, Pages 300-309

  Infante Rivard, Claire ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cytochrome P450; Gene environment interaction; IUGR; Maternal caffeine intake; Maternal smoking

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1;

ADULT; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; COFFEE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PREGNANT WOMAN; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SEX RATIO; SMALL FOR DATE INFANT; SMOKING; THIRD TRIMESTER PREGNANCY; XENOBIOTIC METABOLISM;

CAFFEINE; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; SMOKING; THEOPHYLLINE;

EID: 34250178776     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2007.00825.x     Document Type: Article

References (43)

1. Caubet MS, Comte B, Brazier JL. Determination of urinary 13C-caffeine metabolites by liquid chromatography-mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity. Journal of Pharmaceutical and Biomedical Analysis 2004 34 : 379 389.
2. Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, et al. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clinical Pharmacology and Therapeutics 2001 70 : 121 125.
3. Knutti R, Rothweiler H, Schlatter C. The effect of pregnancy on the pharmacokinetics of caffeine. Archives of Toxicology Supplement 1982 5 : 187 192.
4. Yesair DW, Branfman AR, Callahan MM. Human disposition and some biochemical aspects of methylxanthines. In : The Methylxanthine Beverages and Foods: Chemistry, Consumption, and Health Effects. Editor : Spiller GA. New York : Alan R. Liss, 1984 pp. 215 233.
5. Mirkin BL, Singh S. Placental transfer of pharmacologically active molecules. In : Perinatal Pharmacology and Therapeutics. Editor : Mirkin BL. New York : Academic Press, 1976 pp. 1 69.
6. Hakkola J, Pelkonen O, Pasanen M, Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role of intrauterine toxicity. Critical Reviews in Toxicology 1998 1 : 35 72.
7. Juchau MR, Boutelet-Bochan H, Huang Y. Cytochrome-P450-dependent biotransformation of xenobiotics in human and rodent embryonic tissues. Drug Metabolism Review 1998 30 : 541 568.
8. Weathersbee PS, Lodge R. Caffeine: its direct and indirect effect on reproduction. Journal of Reproductive Medicine 1977 19 : 55 63.
9. Mandel HG. Update on caffeine consumption, disposition and action. Food and Chemical Toxicology 2002 40 : 1231 1234.
10. Dlugosz L, Bracken MB. Reproductive effects of caffeine: a review and theoretical analysis. Epidemiologic Reviews 1992 14 : 83 100.
11. US Food and Drug Administration. Statement by Jere E. Goyan, Commissioner of Food & Drugs. HHS News September 5, 1980. Washington, DC : US Department of Health and Human Services (no p80-36).
12. Fernandes O, Sabharwal M, Smiley T, Pastuszak A, Koren G, Einarson T. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reproductive Toxicology 1998 12 : 435 444.
13. Leviton A, Cowan L. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food and Chemical Toxicology 2002 40 : 1271 1310.
14. Klebanoff MA, Levine RJ, Clemens JD, Wilkins DG. Maternal serum caffeine metabolites and small-for-gestational age at birth. American Journal of Epidemiology 2002 155 : 32 37.
15. Bracken MB, Triche EW, Belanger K, Hellenbrand K, Leaderer BP. Association of maternal caffeine consumption with decrements in fetal growth. American Journal of Epidemiology 2003 157 : 456 466.
16. Clausson B, Granath F, Ekbom A, Lundgren S, Nordmark A, Signorello LB, et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. American Journal of Epidemiology 2002 155 : 429 436.
17. Vik T, Bakketeig LS, Ulla Trygg K, Lund-Larsen K, Jacobsen G. High caffeine consumption in the third trimester of pregnancy: gender-specific effects on fetal growth. Paediatric and Perinatal Epidemiology 2003 17 : 324 331.
18. National Coffee Association of USA. National Coffee Drinking Trends 2002. New York : National Coffee Association of USA, 2002.
19. Knight CA, Knight I, Mitchell DC, Zepp JE. Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the Share of Intake Panel survey. Food and Chemical Toxicology 2004 42 : 1923 1930.
20. De Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Gosheh OH, et al. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003 27 : 165 171.
21. Signorello LB, McLaughlin J. Maternal caffeine consumption and spontaneous abortion. A review of epidmiologic evidence. Epidemiology 2004 15 : 229 239.
22. Relling MV, Lin J-S, Ayers GD, Evans WE. Racial and gender differences in N-acetytrnasferase, xanthine oxidase, and CYP1A2* activities. Clinical Pharmacology and Therapeutics 1992 52 : 643 658.
23. Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicology and Applied Pharmacology 2004 199 : 193 209.
24. Infante-Rivard C, Rivard GE, Yotov WV, Génin E, Weinberg CR, Guiguet M, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. New England Journal of Medicine 2002 347 : 19 25.
25. Infante-Rivard C, Lévy E, Rivard GE, Guiguet M, Feoli-Fonseca JC. Small babies receive the cardiovascular protective apolipoprotein ε2 allele less frequently than expected. Journal of Medical Genetics 2003 40 : 626 629.
26. Arbuckle TE, Wilkins R, Sherman GJ. Birth weight percentiles by gestational age in Canada. Obstetrics and Gynecology 1993 81 : 39 48.
27. Infante-Rivard C. Drinking water contaminants, gene polymorphisms and fetal growth. Environmental Health Perspectives 2004 112 : 1213 1216.
28. Moran P, Dightman DA, Park LK. Nonelectrophoretic genotyping using allele-specific PCR and a dsDNA-specific dye. Biotechniques 1998 24 : 206 208, 210, 212.
29. Barone JJ, Roberts HR. Caffeine consumption. Food and Chemical Toxicology 1996 34 : 119 129.
30. Robins JM, Rotnitzky A, Zhao L. Estimation of regression coefficients when some regressors are not always observed. Journal of the American Statistical Association 1994 89 : 846 866.
31. Schaid DJ, Jacobsen SJ. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. American Journal of Epidemiology 1999 149 : 706 711.
32. Kalow W, Tang BK. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clinical Pharmacology and Therapeutics 1991 50 : 508 519.
33. Brown CR, Jacob P III, Wilson M, Benowitz NL. Changes in rate and pattern of caffeine metabolism after cigarette abstinence. Clinical Pharmacology and Therapeutics 1988 43 : 488 491.
34. Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J, et al. Colorectal Cancer Study Group. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. British Journal of Clinical Pharmacology 2003 55 : 68 76.
35. Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002 12 : 473 478.
36. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. Journal of Biochemistry 1999 125 : 803 808.
37. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. Journal of Biochemistry 1994 116 : 321 326.
38. Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 1998 8 : 411 421.
39. Cook DG, Peacock JL, Feyerabend C, Carey IM, Jarvis MJ, Anderson HR, et al. Relation of caffeine intake and blood concentrations during pregnancy to fetal growth: prospective population based study. British Medical Journal 1996 313 : 1358 1362.
40. Fuller KE. Low birth-weight infants: the continuing ethnic disparity and the interaction of biology and environment. Ethnicity and Disease 2000 10 : 432 445.
41. Infante-Rivard C, Fernández A, David M, Gauthier R, Rivard GE. Coffee and caffeine intake before and during pregnancy and fetal loss. JAMA 1993 270 : 2940 2943.
42. Lawson CC, LeMasters GK, Wilson KA. Changes in caffeine consumption as a signal of pregnancy. Reproductive Toxicology 2004 18 : 625 633.
43. Cnattingius S, Signorello LB, Anneren G, Clausson B, Ekbom A, Ljunger E, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. New England Journal of Medicine 2000 343 : 1839 1845.